Literature DB >> 2578583

Identification of three types of granules in neutrophils of ruminants. Ultrastructure of circulating and maturing cells.

M Baggiolini, U Horisberger, R Gennaro, B Dewald.   

Abstract

The production of three populations of granules during maturation and their occurrence in the neutrophils of a number of ruminants is described. Bone marrow samples from cows, sheep, and goats were fixed, reacted for peroxidase, and examined by transmission electron microscopy. Granule formation was found to occur at three subsequent stages. As in other species including man, it begins with the production of peroxidase-positive granules and is concluded with the production of moderately dark-staining, peroxidase-negative granules of similar size. These two organelles have the characteristics of the azurophil or primary and specific or secondary granules of other species. At an intermediate stage, a different type of peroxidase-negative granule, the large granule, is formed. Its profile is round and markedly larger than those of azurophil and specific granules. The large granules initially have a loose, undulated membrane and fill gradually with matrix which in early forms consists of a central core. Fully developed large granules have a sharply defined membrane and a pale, very uniform content. The two types of peroxidase-negative granules can be distinguished by their sizes and times of formation and also by the appearance of their content which is more coarse and darker in the specific granules. Mature neutrophils from cows, goats, sheep, and an ibex were also examined. Two features are common to all cells viewed: the presence of three types of granules and the preponderance of the large granule population. The results of this study, together with evidence from cell fractionation experiments, suggest that the large granules are a characteristic property of the neutrophils of ruminants.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2578583

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  8 in total

1.  Leukocytic cell sources of airway tissue kallikrein.

Authors:  Isabel T Lauredo; Rosanna M Forteza; Yelena Botvinnikova; William M Abraham
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2003-12-05       Impact factor: 5.464

2.  Preferential inhibition of primary granule release from bovine neutrophils by a Brucella abortus extract.

Authors:  T A Bertram; P C Canning; J A Roth
Journal:  Infect Immun       Date:  1986-04       Impact factor: 3.441

3.  The effect of activation of granulocytes on enzyme release and hydrogen peroxide and superoxide production in buffaloes.

Authors:  V K Singh; T More; S Singh
Journal:  Vet Res Commun       Date:  1997-05       Impact factor: 2.459

4.  Granule enzymes of human and rabbit polymorphonuclear leukocytes: an investigation of enzyme solubility.

Authors:  P D Brown; G B Robinson
Journal:  Inflammation       Date:  1987-03       Impact factor: 4.092

5.  Purification, composition, and activity of two bactenecins, antibacterial peptides of bovine neutrophils.

Authors:  R Gennaro; B Skerlavaj; D Romeo
Journal:  Infect Immun       Date:  1989-10       Impact factor: 3.441

6.  Cytochemical characterization of leucocytes from the seawater teleost, gilthead seabream (Sparus aurata L.).

Authors:  J Meseguer; A López-Ruiz; M Angeles Esteban
Journal:  Histochemistry       Date:  1994-08

7.  Bactenecins, defense polypeptides of bovine neutrophils, are generated from precursor molecules stored in the large granules.

Authors:  M Zanetti; L Litteri; R Gennaro; H Horstmann; D Romeo
Journal:  J Cell Biol       Date:  1990-10       Impact factor: 10.539

8.  Target-Specific Fluorescence-Mediated Tomography for Non-Invasive and Dynamic Assessment of Early Neutrophil Infiltration in Murine Experimental Colitis.

Authors:  Tobias M Nowacki; Philipp Lenz; Dominik Bettenworth; Markus Brückner; Arne Bokemeyer; Phil R Tepasse; Anne Helfen; Moritz Wildgruber; Michel Eisenblätter
Journal:  Cells       Date:  2019-10-28       Impact factor: 6.600

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.